Saturday, May 20, 2023

How to Avoid Scam? Remember this

If someone knew a way to make money, he wouldn't spend his time sharing it with you. He will definitely spend most of his time making money, unless "you" are how he makes money.

如果有人知道有一种赚钱的方法,他不会花时间与你分享这个方法。 他肯定会把大部分时间花在赚钱上, 除非“你”是他的赚钱方式。

Wednesday, December 1, 2021

如何避免掉入投资诈骗的陷阱?

分享给你的家人,亲戚,朋友,同事和邻居吧!让他们避免掉入投资诈骗的陷阱!


大家都想投资致富,但是每一年都有数十千人受骗,损失的金额高达数亿元。

每个人自己或家人,亲戚,朋友,同事,邻居都有曾经接触过投资诈骗的经历!

那要如何避免受骗?以下是专家告诉你如何避免掉入投资诈骗的陷阱的方法。

       
了解投资诈骗的几种特色:

1)披着华丽的外衣,承诺高收益低风险。
2)受害者在短时间内,无法冷静思考下被说服。
3)没有法律上的保障(介绍人或代理人当然说有)。
4)由前政府高官/皇室成员/政治人物担任要职。
5)投入的资金数额庞大,比其他类型的诈骗高。
6)介绍人或代理人从你身上赚取高额的佣金。
7)管理层和代理人刻意的炫耀他们财富和收入。 



受骗者有几个特点:

1) 对投资的知识不足,把投资看的过于简单。
2) 对投资有幻想,希望通过投资改善生活。
3) 外行人,对投资项目没有相关的经验,想快速致富。
4) 对有关投资项目的市场和基本的法律都没有足够的知识。
5) 有关的公司背景和投资资讯等都是由介绍人或代理人提供。
6) 容易信任他人,容易被说服,自己没有好好做功课和调查。
7) 有自己的储蓄或能通过借贷,提供投资的高额资金。



诈骗的手段:

1) 保证投资计划是合法。
2) 讲投资者要听的话:可在短期内获取利润,高回报率。 
3) 提供投资者正式的法律文件/合约,让投资者相信有法律的保障。
4) 向投资者提供保证,如取消投资,可在短期内拿回资金。
5) 让投资者证明,投资有第三方的保障。
6) 诚恳友善的态度,但一翻脸就无情。 
7) 以各种数据来证明投资计划的利润。
8) 眼见为证,让投资者看的见,摸的到。


在进行任何投资前先问自己这些问题:

1) 你对投资项目相关的知识和法律有多了解?有何保障?
2) 你对相关公司的股东,董事,管理,财务,资产,债务有多了解?
3) 你对投资项目的成本,毛利,净利,市场,兢争,产能有多了解?
4) 同样的产品在市场的价格是多少?有多少个供应商?你做了比较吗?
5) 你所有相关的资讯是从那里得到的?你自己做了多少功课和调查?
6) 如何确保的你得到的资讯是正确和真实的?你的投资要如何脱手和套利?
7) 你有亲自向国家银行,证监委员会,直销公会,消费者协会等等查证吗?


你知道吗?

1) 所有投资计划须拥有证监委员会Securities Commission发出的准证。
2) 为了提防对方所提供的准证是伪造的,你最好亲自去证监委员会查证。
3) 证监委员会 Securities Commission 的网站: www.sc.com.my
4) 你可以到公司委员会 www.ssm.com.my 调查相关公司每年的财务报告。
5) 你可在直销公会的网站 www.dsam.org.my 查到合法直销公司的名单。
6) 消费者协会 www.nccc.org.my


曾经在市场上出现过的各种投资诈骗:

1) 农业养殖: 棕油,榴莲,养燕,海草,养鱼,沉香木,养田鸡,火龙果等等。
2) 传统产业: 入股,合资,代理权,连锁店,餐饮业,保健特许经营等等。
3) 设备器材: 自动售水机,自动贩卖机,游戏电脑器材租贷等等。
4) 科技网络: 虚拟货币,网络游戏,通讯服务,网页广告等等。
5) 金融股票: 外汇,期货,集资,众筹,创筹,原始股,海外/天使基金等等。
6) 非法传销: 香精,人参,灵芝,干细胞,胎盘素,生物科技产品等等。
7) 贵重金属: 黄金,白银,金币,採矿计划等等。
8) 各种计划:利息计划,金钱游戏,医疗计划,旅游城,海外土地储备等等。


分享给你的家人,亲戚,朋友,同事和邻居吧!让他们避免掉入投资诈骗的陷阱!




Thursday, June 3, 2021

Market Briefing

Malaysia Led by 27 gains in KLCI components, KLCI soared 12 pts to 1597.9 as market sentiment was boosted by surging oil prices and FCPO, coupled with the government’s pledge to further ramp up in daily vaccination rates next month. Market breadth was bullish as 710 gainers beat 362 losers with a total of 7.4bn shares transacted valued at RM4.1bn. 

Foreign institutions returned as net buyers (+RM139m; 5D: +RM372m) whilst retailers (-RM18m; 5D: +RM298m) joined local institutions (-RM121m; 5D: -RM670m) as the major net sellers.

Outlook After plunging to 1552 (YTD low), KLCI has staged a commendable rebound to end at 1597.6 yesterday as the tussle between slowing economy and elevated Covid-19 infections against further acceleration in vaccination rollouts, abundant liquidity and prevailing low interest rates (BNM may cut OPR by another 25bps on 8 July should the lockdown prolong beyond a month) continue to play out in the market. Key resistances are pegged at 1600-1606-1623 levels whilst supports are situated near 1582-1577-1552 territory. 

Global Asian stocks ended moderately higher as sentiment was boosted by a strong April US ISM manufacturing data and an upbeat Australia GDP report, ahead of the widely focused US jobs data this Friday that could engender further talk of Fed’s policy normalization. 

The Dow jumped as much as 130 pts to 34706 in early trades, led by energy shares as oil rallied to more than two-year high on OPEC+ supply discipline and promising demand prospects. However, the index ended only +25 pts at 34600 as investors assessed the Fed's Beige Book, which highlighted the ongoing labour supply shortage and faster pace of inflation are set to continue in the months ahead.  

Thursday, May 27, 2021

Serba Dinamik

 Key takeaways from Serba Dinamik conference call:

♦️ Serba received the official review request in early May this year and this is the main reason for  the change of financial year end to June. The prolonged COVID-19 pandemic has somewhat limit the ordinary audit process despite >90% of the subsidiaries/material subsidiaries are audited by KPMG.


♦️ No fraudulent related reports have been raised thus far. The review are not particularly on certain transactions or subsidiaries but more on overall operations which include domestic and overseas operations. Some of these issues have been addressed by management and the independent reviews will “give comfort” to the auditors.


♦️ No RPT is related and the additional reviews are not backdated to prior year numbers. The additional review also not extended to Dato’ Karim’s related companies i.e. KPower and SCIB.


♦️ Serba Dinamik has identified a new independent firm to address this issue and the review is guided to be completed by August concurrently with the conclusion of 18MFY21 financial statements (until October 2021 for submission).


♦️ Management reiterates that no disruption to its business operations at this juncture. They have also engaged with financiers and have not received any pullback of banking facilities and credit lines.


♦️ Our view - the explanations given by management may not be able to provide sufficient clarity and comfort to address investors doubt. Expect share price to react negatively and it will remain a major overhang until the company is able to prove the veracity and accuracy of these matters.

Thursday, April 15, 2021

Rubber Products Update

 1. COVID-19 daily new cases in Malaysia breached 2,000. New cases hit 2148 today which is 14% higher than yesterday's 1889. More importantly, it breaks the psychological level of 2000 cases. Sarawak reported the highest infections at 512.

2. This may explain the strong price performance today for gloves companies This may have increased the interest in gloves sector today. As of time of writing, six gloves stocks under our coverage have gained between 6% to 13%.

3. Our BUY calls are fundamentally driven with Kossan (TP: MYR5.45) as preferred pick Sentiment aside, our TP are already assuming long term gloves ASP of USD40 as compared to current ASP of between USD80-100. Our preferred pick is Kossan. In the near term, it should benefit from the nitrile glove shortage. 80% of its sales volume is derived from nitrile gloves, and the rest from latex gloves. Its expansion plan is intact, with Plant 19 fully commissioned in Aug 2020 – bringing total capacity to 32bn ppa. Looking ahead into FY21, the company plans to increase capacity by 1.5bn ppa by constructing Plant 20. This is slated for full commissioning by 1H21.

4. Other BUY calls are Top Glove (TP: MYR6.80), Supermax (TP: MYR8.75), Comfort Gloves (TP: MYR:2.60) and Rubberex (TP: MYR1.60).

RHB Research

Thursday, March 25, 2021

Construction


Mah Sing

 ♦️ The development of the glove production lines are on track. Management said the first performance testing was already done on 17/3, and production should start by mid-April.   

♦️ Mah Sing has already locked in shipment up to June @ $115/1k pieces. First batch of shipment is to the US, Canada and Middle East, followed by Europe, Japan, China and South America. 

♦️ Management has already hired 60 non-factory staff (for the glove office), and is in the process of interviewing/hiring another 40 staff. The company will need 350 workers for the total 12 production lines, and thus far, it has locked in 100 workers through 4 agencies. Glove packing will be outsourced to packing professional firm in order to reduce the amount of fixed costs. 

♦️ Mah Sing has also locked in the supply of raw mat NBR @ US$2.7-3k per tonne, sufficient for the current order up to June. It has also locked in the supply until year end, but has not locked in the prices, as NBR prices are expected to come down based on feedback from NBR suppliers. Management indicated that the cost per box (1k pieces) is estimated at US$40.

♦️ Management is still confident to achieve its RM1.6bn sales target. To recall, Jan-Feb sales were already at RM250m. About RM2.4bn worth of projects will be launched this year.

♦️ Maintain Buy, TP: RM0.97

Tuesday, March 9, 2021

Top Glove

Top Glove (RM5.18, noon closing) by HG Tan

2Q core PAThAMI of RM2.865.1bn (+20.7% QoQ, +25x YoY ) brought 1HFY21 core PATAMI to RM5.220.9bn (22x YoY). 

Analysts will say it is is in line as their full yr forecasts are around RM10 to 10.5bn (see Edge Daily today, pg 9). 

Personally, believe results are aboved given the lead time taken to deliver earnings. Estimate full yr net profit to be closer to RM12bn in FY21

Declared DPS of 25.2 sen (1Q21: 16.5sen), ex on 23 March. 1HFY21: 41.7 sen., 1HFY20: None. 

GHW maintains Buy call with TP of RM8.06

There will be a Zoom meeting in afternoon. Analyst will issue report later

For Top Glove, given the dented sentiments with volatile share prices and investors attention on economuc recovery stocks, believe analysts' esply the brokers analysts (including our analyst) will hesitate in revising up earnings and TPs.

Personally believe analysts will remain behind the curve on earnings forecasts of Top Glove 🤣

Top Glove Result

1. Earnings matched expectations. 1HFY21 earnings of MYR5.23bn makes up 51% of consensus and 49% of our full year estimates. 1HFY21 earnings surged 23x YoY due to better ASPs and higher volume of gloves sold.

2. 2QFY21 earnings improved 21% QoQ. Higher ASP supported the increase in better earnings.

3. Announced 25.2 sen dividend. Top Glove paid 70% of its profit in 2QFY21 as promised. Recall that the Company has pledged to increase its payout ratio to 70% from 50% for FY21 beginning 2QFY21 onwards.

4. Prospects. Top Glove stated that "Global glove demand is estimated to grow from a pre-pandemic level of about 10% per annum to about 15% per annum post-pandemic, following increase in usage coupled with heightened hygiene awareness. To ensure it remains well-positioned to meet the continued strong glove demand, the Group will continue to pursue organic expansion, inorganic expansion and strategic investments.

RHB Research

Comments on Top Glove results by HG Tan :

As per my watsapp yestetday, personally construed TG's, 1HFY21 results to be aboved expectations as management guided that 2H is better than 1H.

With locked in sales and normalisation in production (2Q disrupted by closure of factories), expect earnings to trend higher in 3Q.

Personally estimate full yr FY21 earnings to come closer to RM12bn versus consensus/GHW's projection of RM10 to 10.5bn.

Expect FY22 earnings to ease but probably not as sharp as 50% reduction as anticipated by GHW/consensus given the lead time in delivering earnings

Believe our analyst Gan Huan Wen is reluctant to revise up FY21 earnings as it may translate into higher TP.. As it is, he has previously revised down TP following the sharp fall in mkt price of TG...

Judging from the reply of Tan Sri Lim when asked whether the group will continue to pay 70% of net profit as dividend in FY22, the reply alluding to positive rather than negative.. As such, can expect another high dividend year in FY22.

Believe the commendable dividends will cushion share prices. 

Meanwhile, funds raise via dual primary listing of TG in HK will further strengthen its war chest enriched by the strong cashflows. This will enhance its competitive edge in pursuing M&A when opportunities arise.

Tuesday, March 2, 2021

Corporate News

 •* AMMB Holdings Bhd’s* net profit for the third quarter ended Dec 31, 2020 (3QFY21) fell 30.96% to RM263.83 million from RM382.15 million a year ago, due to higher allowance for impairment on loans, advances and financing. The banking group’s quarterly revenue also slipped 11.81% to RM2.09 billion, from RM2.37 billion a year ago, its filing to Bursa Malaysia showed. AMMB did not declare any dividend for the latest quarter.

•* HeiTech Padu Bhd* has won a RM33.92 million contract to provide maintenance services for the Malaysian Immigration System (myIMMs). The technology services provider said it signed the three-year contract with the Immigration Department on March 1. The contract period started on Feb 18.

•* Pharmaniaga Bhd* has appointed Datuk Seri Mohamed Shazalli Ramly as the non-independent non-executive chairman of Pharmaniaga Bhd effective March 1, 2021. Meanwhile, Boustead's executive director of group business development Izaddeen Daud has also joined the board of Pharmaniaga as a non-independent and non-executive director.

•* Top Glove Corp Bhd’s* executive chairman Tan Sri Dr Lim Wee Chai has purchased more shares of the group, as the counter fell to an eight-month low. Lim has raised his direct shareholding in the group to 26.419% or 2.11 billion shares, after he acquired 4.04 million shares at RM4.9287 each, Top Glove’s filing with Bursa Malaysia today showed.  Lim also has an indirect stake of 8.651% or 692.19 million shares in Top Glove, the group said.

•* Advancecon Holdings Bhd* said its 30%-owned Advancecon Sarawak Sdn Bhd had bagged its single-largest contract worth RM153.5 million to undertake earthworks in the Samalaju Industrial Park, Bintulu, Sarawak. The contract was awarded by Wenan Steel (Malaysia) Sdn Bhd to Advancecon Sarawak. Wenan is building an iron and steel production complex there. Advancecon said the contract is in addition to the group’s ongoing works in Sarawak, namely two packages for Pan Borneo Highway Sarawak and two roadwork contracts from the Upper Rajang Development Agency (URDA).

•* Sime Darby Plantation Bhd* has established an Expert Stakeholder Human Rights Assessment Commission, and appointed Impactt Ltd as a third-party assessor to conduct a comprehensive evaluation of the group’s labour practices across its Malaysian operations. For the stakeholder panel, the group said its members include Shift (the leading centre of expertise on the UN Guiding Principles on Business and Human Rights), migrant worker rights activist and human rights researcher Andy Hall, and a representative of the National Union of Plantation Workers (NUPW).

•* Uzma Bhd* is acquiring stakes in two renewable energy (RE) companies for RM5.39 million, in a bid to enter the RE sector with a primary focus on solar energy. Uzma said it has entered into a conditional share sale agreement with Mohd Syahrul Nizar Abdul Ghani to acquire a 49% stake in Suria Infiniti Sdn Bhd and a 100% stake in Mahendran Surya Innovations Sdn Bhd. The oil and gas services group has mulled entering the RE space since late 2019, eyeing projects under Large Scale Solar 4 (LSS4) that were opened for bidding late last year, as well as opportunities amid the high portion of NEM quota that was not utilised.